BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4549695)

  • 1. Rosette formation in Hodgkin's disease.
    Swain A; Trounce JR
    Oncology; 1974; 30(6):449-57. PubMed ID: 4549695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormal formation of rosette (E and EAC) in Hodgkin's disease].
    Lenzini L; Rottoli L; Rottoli P
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1579-83. PubMed ID: 1085157
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosette-forming lymphocytes in Hodgkin's disease.
    Cohnen G; Augener W; Brittinger G; Douglas SD
    N Engl J Med; 1973 Oct; 289(16):863. PubMed ID: 4543492
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution of B and T lymphocytes in the peripheral blood of patients with Hodgkin's disease.
    Many A; Biniaminov M; Rosenthal E; Aghai E; Ramot B
    Acta Haematol; 1976; 56(1):1-6. PubMed ID: 822670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rosette test in Hodgkin's disease. Relation to the presence of antilymphocyte antibodies].
    Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):565-8. PubMed ID: 4615726
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of maintenance MOPP/COPP treatment on the number and function of peripheral T- and B-lymphocytes in Hodgkin's disease during remission].
    Płuzańska A; Kałuzna W
    Pol Arch Med Wewn; 1981 Jun; 65(6):475-81. PubMed ID: 6973752
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological monitoring during chemotherapy for advanced Hodgkin's disease.
    Alexopoulos CG; Wiltshaw E
    Cancer; 1978 Dec; 42(6):2631-40. PubMed ID: 310334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of T lymphocytes in the spleen in Hodgkin's disease.
    Kaur J; Spiers AS; Catovsky D; Galton DA
    Lancet; 1974 Oct; 2(7884):800-2. PubMed ID: 4138221
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: T and B lymphocytes in spleen in Hodgkin's disease.
    Joseph RR; Belpomme D
    Lancet; 1975 Mar; 1(7909):747-8. PubMed ID: 47511
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Lymphocytes in spleen in Hodgkin's disease.
    Grifoni V; Del Giacco GS; Manconi PE; Tognella S; Mantovani G
    Lancet; 1975 Feb; 1(7902):332-3. PubMed ID: 46472
    [No Abstract]   [Full Text] [Related]  

  • 12. Depletion of thymus dependent lymphocytes in Hodgkin's disease.
    Andersen E
    Scand J Haematol; 1974; 12(4):263-9. PubMed ID: 4545783
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T and B blocking factors in Hodgkin's disease.
    Bentwich R; Cohen R; Brautbar C
    Adv Exp Med Biol; 1976; 66():685-90. PubMed ID: 1083664
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
    Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor in Hodgkin's disease.
    Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
    Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 19. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
    Biniaminov M; Ramot B
    Lancet; 1975 Feb; 1(7904):464. PubMed ID: 48661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.